Page 1004 - Williams Hematology ( PDFDrive )

978 Part VII: Neutrophils, Eosinophils, Basophils, and Mast Cells Chapter 63: Basophils, Mast Cells, and Related Disorders 979

31. Siegmund R, Vogelsang H, Machnik A, et al: Surface membrane antigen alteration on 66. Wershil BK, Wang ZS, Gordon JR, et al: Recruitment of neutrophils during IgE-
blood basophils in patients with Hymenoptera venom allergy under immunotherapy. J dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial
Allergy Clin Immunol 106:1190–1195, 2000. inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J Clin
32. Juhlin L, Michaelsson G: A new syndrome characterised by absence of eosinophils and Invest 87:446–453, 1991.
basophils. Lancet 1:1233–1235, 1977. 67. Mukai K, Matsuoka K, Taya C, et al: Basophils play a critical role in the development
33. Tracey R, Smith H: An inherited anomaly of human eosinophils and basophils. Blood of IgE-mediated chronic allergic inflammation independently of T cells and mast cells.
Cells 4:291–300, 1978. Immunity 23:191–202, 2005.
34. Mitchell EB, Platts-Mills TA, Pereira RS, et al: Basophil and eosinophil deficiency in 68. Ong YE, Menzies-Gow A, Barkans J, et al: Anti-IgE (omalizumab) inhibits late-phase
a patient with hypogammaglobulinemia associated with thymoma. Birth Defects Orig reactions and inflammatory cells after repeat skin allergen challenge. J Allergy Clin
Artic Ser 19:331, 1983. Immunol 116:558–564, 2005.
35. Dvorak AM, Mihm MC Jr, Dvorak HF: Morphology of delayed-type hypersensitivity 69. Conner E, Bochner BS, Brummet M, et al: The effect of etanercept on the human cuta-
reactions in man. II. Ultrastructural alterations affecting the microvasculature and the neous allergic response. J Allergy Clin Immunol 121:258–260, 2008.
tissue mast cells. Lab Invest 34:179–191, 1976. 70. Yu M, Tsai M, Tam SY, et al: Mast cells can promote the development of multiple fea-
36. Arinobu Y, Iwasaki H, Gurish MF, et al: Developmental checkpoints of the basophil/ tures of chronic asthma in mice. J Clin Invest 116:1633–1641, 2006.
mast cell lineages in adult murine hematopoiesis. Proc Natl Acad Sci U S A 102:18105– 71. Yu M, Eckart MR, Morgan AA, et al: Identification of an IFN-γ/mast cell axis in a
18110, 2005. mouse model of chronic asthma. J Clin Invest 121:3133–3143, 2011.
37. Qi X, Hong J, Chaves L, et al: Antagonistic regulation by the transcription factors C/ 72. MacGlashan DW Jr, Bochner BS, Adelman DC, et al: Down-regulation of FcεRI expres-
EBPα and MITF specifies basophil and mast cell fates. Immunity 39:97–110, 2013. sion on human basophils during in vivo treatment of atopic patients with anti-IgE
38. Mukai K, BenBarak MJ, Tachibana M, et al: Critical role of P1-Runx1 in mouse basophil antibody. J Immunol 158:1438–1445, 1997.
development. Blood 120:76–85, 2012. 73. Yamaguchi M, Lantz CS, Oettgen HC, et al: IgE enhances mouse mast cell FcεRI expres-
39. Hastie R: A study of the ultrastructure of human basophil leukocytes. Lab Invest sion in vitro and in vivo: Evidence for a novel amplification mechanism in IgE-dependent
31:223–231, 1974. reactions. J Exp Med 185:663–672, 1997.
40. Ronnberg E, Melo FR, Pejler G: Mast cell proteoglycans. J Histochem Cytochem 60:950– 74. Kawakami T, Galli SJ: Regulation of mast-cell and basophil function and survival by
962, 2012. IgE. Nat Rev Immunol 2:773–786, 2002.
41. Rothenberg ME, Caulfield JP, Austen KF, et al: Biochemical and morphological char- 75. Matsuda K, Piliponsky AM, Iikura M, et al: Monomeric IgE enhances human mast cell
acterization of basophilic leukocytes from two patients with myelogenous leukemia. J chemokine production: IL-4 augments and dexamethasone suppresses the response.
Immunol 138:2616–2625, 1987. J Allergy Clin Immunol 116:1357–1363, 2005.
42. Metcalfe DD, Bland CE, Wasserman SI: Biochemical and functional characterization of 76. James LC, Roversi P, Tawfik DS: Antibody multispecificity mediated by conformational
proteoglycans isolated from basophils of patients with chronic myelogenous leukemia. diversity. Science 299:1362–1367, 2003.
J Immunol 132:1943–1950, 1984. 77. Galli SJ, Askenase PW. Cutaneous basophil hypersensitivity, in The Reticuloendothelial
43. Porter JF, Mitchell RG: Distribution of histamine in human blood. Physiol Rev 52:361– System: A Comprehensive Treatise, edited by Abramoff P, Phililps S, Escobar N, p 321.
381, 1972. Plenum, New York, 1986.
44. Wernersson S, Pejler G: Mast cell secretory granules: Armed for battle. Nat Rev Immu- 78. Galli SJ, Nakae S, Tsai M: Mast cells in the development of adaptive immune responses.
nol 14:478–494, 2014. Nat Immunol 6:135–142, 2005.
45. Oh C, Suzuki S, Nakashima I, et al: Histamine synthesis by non-mast cells through 79. Rodewald HR, Feyerabend TB: Widespread immunological functions of mast cells:
mitogen-dependent induction of histidine decarboxylase. Immunology 65:143–148, Fact or fiction? Immunity 37:13–24, 2012.
1988. 80. McLachlan JB, Shelburne CP, Hart JP, et al: Mast cell activators: A new class of highly
46. Xu X, Zhang D, Zhang H, et al: Neutrophil histamine contributes to inflammation in effective vaccine adjuvants. Nat Med 14:536–541, 2008.
mycoplasma pneumonia. J Exp Med 203:2907–2917, 2006. 81. Brown SJ, Galli SJ, Gleich GJ, et al: Ablation of immunity to Amblyomma americanum
47. Saxena SP, Brandes LJ, Becker AB, et al: Histamine is an intracellular messenger medi- by anti-basophil serum: Cooperation between basophils and eosinophils in expression
ating platelet aggregation. Science 243:1596–1599, 1989. of immunity to ectoparasites (ticks) in guinea pigs. J Immunol 129:790–796, 1982.
48. Galli SJ, Kitamura Y: Genetically mast-cell-deficient W/W and Sl/Sl mice. Their value 82. Matsuda H, Watanabe N, Kiso Y, et al: Necessity of IgE antibodies and mast cells for
v
d
for the analysis of the roles of mast cells in biologic responses in vivo. Am J Pathol manifestation of resistance against larval Haemaphysalis longicornis ticks in mice.
127:191–198, 1987. J Immunol 144:259–262, 1990.
49. Galli SJ, Kalesnikoff J, Grimbaldeston MA, et al: Mast cells as “tunable” effector and 83. Abraham SN, St John AL: Mast cell-orchestrated immunity to pathogens. Nat Rev
immunoregulatory cells: Recent advances. Annu Rev Immunol 23:749–786, 2005. Immunol 10:440–452, 2010.
50. Galli SJ, Tsai M, Piliponsky AM: The development of allergic inflammation. Nature 84. Di Nardo A, Vitiello A, Gallo RL: Cutting edge: Mast cell antimicrobial activity is mediated
454:445–454, 2008. by expression of cathelicidin antimicrobial peptide. J Immunol 170:2274–2278, 2003.
51. Galli SJ, Grimbaldeston M, Tsai M: Immunomodulatory mast cells: Negative, as well as 85. Maurer M, Wedemeyer J, Metz M, et al: Mast cells promote homeostasis by limiting
positive, regulators of immunity. Nat Rev Immunol 8:478–486, 2008. endothelin-1-induced toxicity. Nature 432:512–516, 2004.
52. Gordon JR, Galli SJ: Mast-cells as a source of both preformed and immunologically 86. Schneider LA, Schlenner SM, Feyerabend TB, et al: Molecular mechanism of mast cell
inducible TNF-α cachectin. Nature 346:274–276, 1990. mediated innate defense against endothelin and snake venom sarafotoxin. J Exp Med
53. Walsh LJ, Trinchieri G, Waldorf HA, et al: Human dermal mast cells contain and release 204:2629–2639, 2007.
tumor necrosis factor α, which induces endothelial leukocyte adhesion molecule 1. Proc 87. Piliponsky AM, Chen CC, Nishimura T, et al: Neurotensin increases mortality and mast
Natl Acad Sci U S A 88:4220–4224, 1991. cells reduce neurotensin levels in a mouse model of sepsis. Nat Med 14:392–398, 2008.
54. de Paulis A, Prevete N, Fiorentino I, et al: Expression and functions of the vascu- 88. Mallen-St Clair J, Pham CT, Villalta SA, et al: Mast cell dipeptidyl peptidase I mediates
lar endothelial growth factors and their receptors in human basophils. J Immunol survival from sepsis. J Clin Invest 113:628–634, 2004.
177:7322–7331, 2006. 89. Chan CY, St John AL, Abraham SN: Mast cell interleukin-10 drives localized tolerance
55. Min B: Basophils: What they “can do” versus what they “actually do”. Nat Immunol in chronic bladder infection. Immunity 38:349–359, 2013.
9:1333–1339, 2008. 90. Bannert N, Farzan M, Friend DS, et al: Human mast cell progenitors can be infected by
56. Sullivan BM, Liang HE, Bando JK, et al: Genetic analysis of basophil function in vivo. macrophagetropic human immunodeficiency virus type 1 and retain virus with matu-
Nat Immunol 12:527–535, 2011. ration in vitro. J Virol 75:10808–10814, 2001.
57. Karasuyama H, Mukai K, Obata K, et al: Nonredundant roles of basophils in immunity. 91. Sundstrom JB, Little DM, Villinger F, et al: Signaling through Toll-like receptors trig-
Annu Rev Immunol 29:45–69, 2011. gers HIV-1 replication in latently infected mast cells. J Immunol 172:4391–4401, 2004.
58. Rivera J, Gilfillan AM: Molecular regulation of mast cell activation. J Allergy Clin Immu- 92. Sundstrom JB, Ellis JE, Hair GA, et al: Human tissue mast cells are an inducible reser-
nol 117:1214–1225; quiz 1226, 2006. voir of persistent HIV infection. Blood 109:5293–5300, 2007.
59. Kraft S, Kinet JP: New developments in FcεRI regulation, function and inhibition. Nat 93. Li Y, Li LX, Wadley R, et al: Mast cells/basophils in the peripheral blood of allergic
Rev Immunol 7:365–378, 2007. individuals who are HIV-1 susceptible due to their surface expression of CD4 and the
60. Koshino T, Teshima S, Fukushima N, et al: Identification of basophils by immuno- chemokine receptors CCR3, CCR5, and CXCR4. Blood 97:3484–3490, 2001.
histochemistry in the airways of post-mortem cases of fatal asthma. Clin Exp Allergy 94. St John AL, Rathore AP, Yap H, et al: Immune surveillance by mast cells during dengue
23:919–925, 1993. infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance.
61. Finkelman FD: Anaphylaxis: Lessons from mouse models. J Allergy Clin Immunol Proc Natl Acad Sci U S A 108:9190–9195, 2011.
120:506–515; quiz 516–517, 2007. 95. Profet M: The function of allergy: Immunological defense against toxins. Q Rev Biol
62. Jonsson F, Daeron M: Mast cells and company. Front Immunol 3:16, 2012. 66:23–62, 1991.
63. Galli SJ, Tsai M, Marichal T, et al: Approaches for analyzing the roles of mast cells and 96. Metz M, Piliponsky AM, Chen CC, et al: Mast cells can enhance resistance to snake and
their proteases in vivo. Adv Immunol 125:45–127, 2015. honeybee venoms. Science 313:526–530, 2006.
64. Reber LL, Marichal T, Galli SJ: New models for analyzing mast cell functions in vivo. 97. Haftenberger M, Laussmann D, Ellert U, et al: [Prevalence of sensitisation to aeraoaller-
Trends Immunol 33:613–625, 2012. gens and food allergens: Results of the German Health Interview and Examination Sur-
65. Ebo DG, Bridts CH, Hagendorens MM, et al: Basophil activation test by flow cytometry: vey for Adults (DEGS1)] [in German]. Bundesgesundheitsblatt Gesundheitsforschung
Present and future applications in allergology. Cytometry B Clin Cytom 74:201–210, 2008. Gesundheitsschutz 56:687–697, 2013.

Kaushansky_chapter 63_p0965-0982.indd 979 9/18/15 11:01 PM